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Abstract 28 
 29 
Background: Comorbid anxiety and depression are common in patients with 30 
rheumatoid arthritis (RA) but often under-recognised and treated, contributing to 31 
worse outcomes. NICE recommends that RA patients should be offered a holistic 32 
annual review, including an assessment of mood.  33 
 34 
Aim: To explore patients' perspectives of anxiety and depression in RA and 35 
preferences for disclosure and management of mood problems. 36 
 37 
Design and Setting: Qualitative interview study with patients recruited from a nurse-38 
led RA annual review clinic.  39 
 40 
Method: Patients attending the clinic who scored ≥3 on the case-finding questions 41 
(PHQ2 and GAD2) were invited for interview. Data were analysed thematically using 42 
principles of constant comparison. 43 
 44 
Results: Participants recognised a connection between their RA and mood, though 45 
this was perceived variably. Some lacked candidacy for care, normalising their mood 46 
problems. Fear of stigmatisation, a lack of time and the perception that clinicians 47 
prioritise physical over mental health problems recursively affected help-seeking. 48 
Good communication and continuity of care were perceived to be integral to 49 
disclosure of mood problems. Participants expressed a preference for psychological 50 
therapies, though reported problems accessing care. Some perceived medication to 51 
be offered as a ‘quick fix’ and feared potential drug interactions.  52 
 53 
Conclusion: Prior experiences can lead patients with RA and co-morbid anxiety and 54 
depression to feel they lack candidacy for care. Provision of equal priority to mental 55 
and physical health problems by GPs and improved continuity of care could help 56 
disclosure of mood concerns. Facilitation of access to psychological therapies could 57 
improve outcomes for both mental and physical health problems. 58 
 59 
How this fits in 60 
 61 
Anxiety and depression are common in RA and negatively impact on 62 
outcomes. Patients reported normalising their mood problems, perceived clinicians 63 
to prioritise physical over mental health concerns and reported GP appointments to 64 
be anxiety provoking, recursively affecting help-seeking. Use of the PHQ-2 and 65 
GAD-2 questions in the context of an annual review for patients with RA may 66 
promote discussion about mood, thus enabling mood problems to be addressed 67 
through signposting to appropriate interventions, improving care and outcomes.  68 
 69 
Introduction 70 
Rheumatoid Arthritis (RA) is a common inflammatory long-term condition 71 
(LTC) leading to joint pain, swelling and deformity (1). In common with other LTCs 72 
(2), RA is associated with an increased prevalence of both depression and anxiety 73 
(estimated to affect 39% and 20% respectively) (3, 4). Co-existent mood disorders in 74 
RA are associated with reduced remission rates (5), increased morbidity and 75 
mortality (6) and raised healthcare costs (2). Despite this studies suggest that 76 
anxiety and depression are under-recognised and under-treated (7). Therefore, the 77 
recognition and treatment of mood disorders in RA should be a health care priority to 78 
improve outcomes. 79 
Although the Quality Outcomes Framework (QOF) incentivises an annual 80 
review of RA this doesn't specify mood assessment (8). However, the National 81 
Institute for Health and Care Excellence (NICE) does recommend that clinicians 82 
assess mood within the context of an annual review (QS33). Whether this should 83 
occur in primary or secondary care or how mood should be assessed is not specified 84 
(9). 85 
Despite QOF incentives and NICE guidelines promoting a RA annual review, 86 
evidence suggests that the care of patients with RA is fragmented (10). A recent 87 
national GP survey showed that primary care RA annual reviews focus on CVD and 88 
osteoporosis screening, leading to duplication of some tests, whilst other key 89 
elements, such as case-finding for anxiety and depression are lacking (11).  90 
The NICE guidelines for identification of depression in adults with chronic 91 
physical health problems (12) suggests the most sensitive tools for case-finding are 92 
the GHQ-28 (General Health Questionnaire) and the two-stem questions of the 93 
PHQ-9 (Patient Health Questionnaire), with the two-stem questions being popular 94 
due to their ease of use (13).  95 
 There is evidence that psychological interventions in RA are effective in the 96 
management of anxiety, depression and pain (14, 15). Self-management 97 
interventions to support patients to manage aspects of their RA independently have 98 
also been found to have positive effects on pain and psychological well-being (16, 99 
17).  100 
There is limited literature exploring patient and practitioner perspectives on 101 
the identification and management of mood disorders in RA.  102 
 Since RA is associated with an increased prevalence of anxiety and 103 
depression and that the case-finding questions are useful screening tools in other 104 
LTCs, further research is required to identify barriers and facilitators to disclosure.  105 
 A nurse-led RA annual review clinic was established at two community 106 
hospitals in the Midlands, England. This study aimed to recruit patients with RA and 107 
co-morbid mood disorders from the annual review clinic to interview, in order to 108 
explore their perspectives of anxiety and depression in RA and preferences for 109 
disclosure and management of mood problems. 110 
 This paper reports analysis of interviews with patients who had attended the 111 
review clinic. 112 
 113 
Methods 114 
Recruitment 115 
Patients with established RA normally attending consultant rheumatology 116 
clinics for review, were invited to attend a pilot nurse-led annual review clinic which 117 
aimed to offer a more holistic assessment than than their routine secondary care 118 
review. Patients were asked to complete a short questionnaire, including key 119 
domains highlighted by NICE (18). This had been co-designed with a local patient 120 
group who suggested changes to make it more easily readable. This included work 121 
status, self-reported co-morbidities, disease activity and physical function, together 122 
with the Patient Health Questionnaire (PHQ-2) and Generalised Anxiety Disorder 123 
(GAD-2), to case-find for co-morbid anxiety and depression (19, 20).   124 
Between October 2015 to August 2016, patients scoring ≥ 3 on the PHQ-2 125 
and/or GAD-2 (table 1) were invited to take part in a single face to face interview. 126 
Ethical approval was obtained. 127 
 128 
Interviews 129 
Interviews were conducted by an academic GP registrar (AM) supervised by 130 
an experienced qualitative researcher (CCG). The interviewer introduced themselves 131 
as a researcher and did not disclose their identity as a GP registrar, to ensure that 132 
participants spoke more freely about their experiences of consulting health care 133 
professionals. Written consent was obtained prior to each interview. 134 
Interviews were face-to-face and semi-structured, supported by a topic guide. 135 
The interviewer explored patients' perspectives of anxiety and depression in RA, 136 
views of the nurse-led annual review clinic and experiences of discussing mood 137 
problems with health care professionals and preferences for management. The topic 138 
guide was refined during the course of the study, taking account of emerging 139 
analysis. This included the addition of questions to further explore past experiences 140 
of help-seeking for anxiety and depression. 141 
All interviews were audio-recorded and lasted between 12-73 minutes, with an 142 
average length of 34 minutes. 14 interviews were required to reach data saturation. 143 
 144 
Analysis 145 
The first seven interviews were transcribed verbatim by the interviewer to 146 
increase familiarity with the data. An independent transcription company was 147 
subsequently used, but each transcript was checked against the digital recording 148 
and anonymised by the interviewer (AM). Analysis began as soon as the first 149 
transcript was available. Therefore, data collection and analysis were conducted 150 
concurrently, enabling modification of the topic guide to reflect emerging themes. 151 
Data were analysed using principles of constant comparison (21). In order to 152 
generate conceptual themes, inductive coding of text segments, followed by re-153 
coding and memo writing was used. Regular meetings took place between the study 154 
team members to agree analysis and salient themes. 155 
Following analysis of the first seven transcripts, ‘access to care’ was noted to 156 
be a key emerging theme. Therefore, a secondary analysis was performed using a 157 
framework approach (22). This included three important concepts surrounding 158 
Dixon-Woods’ model of access to care. (23, 24). Candidacy, referred to the process 159 
by which a person’s eligibility to use a service is formulated through their local 160 
interactions with health services. Concordance, indicated the importance of a match 161 
between a users’ and practitioners’ narrative and successful access to an 162 
intervention. Recursivity referred to the influence of a users’ experiences of health 163 
services on their future help-seeking. 164 
 165 
Results 166 
171 patients attending the nurse-led annual review clinic completed the 167 
questionnaire, with 48 (28%) scoring ≥ 3 on the case-finding questions, suggesting 168 
that they were anxious and/ or depressed. Of 29 invited to be interviewed, 14 agreed 169 
to participate. From the 15 who did not participate, 5 did not respond to our 170 
telephone calls, 2 declined due to poor physical health, 1 reported they were too 171 
busy and the rest who declined, disclosed no reason. Table 2 summarises the 172 
characteristics of the 14 participants, who were all White British, reflecting the 173 
demographics of the local area. More females participated, reflecting the higher 174 
prevalence of RA in women and the proportion of females attending the clinic (68%). 175 
The majority were retired, with an average age of 63.  176 
Key themes that will be presented include ‘making the link’, ‘stigma and 177 
shame’, ‘who to talk to?’ and ‘what’s on offer?’ Data are given to support analysis, 178 
with a participant identifier. 179 
 180 
Making the link 181 
Participants perceived their RA to negatively impact on their mood, suggesting 182 
this was due to joint pain or loss of function. Some normalised this as an expected 183 
response to any LTC. 184 
"I think with any illness low mood could be a problem. Especially when you've been 185 
used to being able to do so much, then you come down to doing so little really. It's a 186 
huge change" P2 187 
 Some participants perceived their mood to negatively impact on their RA, 188 
precipitating flares. 189 
"She said, ‘Do you get depressed?’ and I said, ‘Not a lot, no, not really,’ but it’s only 190 
until afterwards when you think about it and you think, ‘Yes, you do really,’ and it is 191 
connected to the arthritis. It does give me flare-up, no question about it." P8 192 
 However, other participants, perceived their mood and RA to be separate. 193 
"I think a lot of my anxiety and depression is to do with my personality, and I'm the 194 
person I am, with or without my arthritis.” P7 195 
           Some participants described having only recognised the link between their RA 196 
and mood when this was pointed out by a healthcare professional. 197 
“…when she was saying it I was thinking, god, I feel like that, you know, it’s so, it’s 198 
so, like when somebody else said it, I thought, well I’m not on my own, somebody 199 
else must feel like that.” P14 200 
Thus, most participants recognised an interaction between their RA and 201 
mood, though this was perceived variably. Some only recognised a link when this 202 
was suggested by a healthcare professional, facilitating discussion of mood 203 
problems during future RA reviews. Others normalised mental health problems, 204 
potentially resulting in them not seeking help. 205 
 206 
Stigma and shame 207 
Several participants reported having felt too embarrassed to disclose their mental 208 
health concerns to their GP, with some perceiving their low mood as a sign of 209 
weakness.  210 
“It was particularly at first because I had been active and I suppose periodically, you 211 
might anyway, feel a bit low you know, when things get on top of you a bit…but 212 
certainly I did at first, I felt a bit inadequate and don’t like to admit weakness and stuff 213 
like that…” P12 214 
 Thus, fear of stigmatization was a significant barrier to help-seeking for mood 215 
problems.  216 
 217 
Who to talk to? 218 
 Several participants described appointments with their GP as anxiety-219 
provoking which recursively affected future help-seeking for mental health problems. 220 
Some admitted telling their doctor they were fine in order to finish their consultation 221 
quickly, meaning any underlying problems were not addressed. 222 
"I get ever so anxious. I'm not good with, when I have doctor's appointments or 223 
medical appointments. I tend to go in and say yeah I'm fine, just so I can get out 224 
again." P7 225 
 Some participants suggested that GPs prioritise physical above mental health 226 
problems.  227 
"…doctors are busy enough with physical complaints." P2 228 
Several participants described past negative experiences of help-seeking as 229 
barriers to disclosure of mental health concerns. In addition to a lack of time, some 230 
participants perceived their GP not to listen to their concerns. 231 
“There are a lot of people in that surgery and you go in, you sit down and you’ve got 232 
five or ten minutes and then you’re coming back out again and you forget half the 233 
stuff you want to really talk about because I’ve only gone, usually, for my medication.  234 
It’s just when he does actually say, ‘How do you feel?’  I just say, ‘I feel really down’ 235 
and he briefly asks me why and I don’t feel like I have time to tell him before he’s 236 
giving me the leaflet.” P13 237 
Some participants perceived their GP to be intimidating, which recursively 238 
affected future help-seeking for psychological problems. 239 
“And you go in and he just looks at you, you know, and I think to myself, well I’m not 240 
telling you how I feel, you know……God, well he just sits there and he’s very stern 241 
looking, and you go in, and he’ll say ‘what can I do for you?’, and you think nothing, 242 
I’m out the door!” P14 243 
Several participants also described a lack of continuity of care and difficulty 244 
accessing appointments when required with their GP as barriers to the disclosure of 245 
mood problems. 246 
“I’ve been there years and years. I just find them a waste of time. You never get to 247 
see a doctor. You get palmed off with anybody. You’re lucky if you see a doctor 248 
there, anybody. I don’t feel they are bothered.” P9 249 
Other participants described establishing positive relationships with their GP 250 
influenced by body language and rapport which helped to facilitate disclosure of 251 
mental health concerns.  252 
“I just think he’d got a really big heart and I think he was very, very understanding of 253 
how you might be feeling and very, very supportive indeed.” P11 254 
Participants recognized the pressure of restricted appointment times on GPs, 255 
but felt that provision of time during individual appointments and encouragement to 256 
attend follow-up would be integral to disclosure of psychological concerns. 257 
“I suppose it’s because they are so busy and as I’ve said, I do understand where 258 
they’re coming from, they have so many people to deal with…and they’ve only got a 259 
certain length of time, you know, they’re not, whilst there’s some brilliant doctors 260 
about and there undoubtedly is, GPs I mean, they do have a really tough job…” P12 261 
 262 
"He’s just very approachable. You just can talk to him about anything. I did go a few 263 
times and he said I must come back." P8 264 
In summary, some participants perceived their GP prioritised physical above 265 
mental health concerns and reported their appointments to be anxiety-provoking, 266 
recursively affecting help-seeking. Lack of time and poor continuity of care were 267 
perceived to be further barriers to disclosure of mood problems. However, 268 
participants suggested that good communication and encouragement to attend 269 
follow-up would facilitate discussion of psychological concerns. 270 
 271 
What’s on offer? 272 
Participants had different views on the use of medication for anxiety and 273 
depression. Some cited a preference for non-pharmacological treatments over anti-274 
depressants.  275 
“I think at the end of the day I think I’d go down the line of, because I take a lot of 276 
medication, go down the line of perhaps talking to somebody first, definitely try that 277 
before I had any medication.” P14 278 
Another participant was prompted by the RA annual review nurse to consider that 279 
a medication change could be helpful. 280 
"...she said to me, have you tried a different anti-depressant, because I've been on 281 
the Fluoxetine for several years, and she said there are anti-depressants that are for 282 
social anxiety..." P7 283 
Others perceived medication to be offered as a ‘quick-fix’ option, due to reduced 284 
funding for psychological therapies. As a result, they had considered private therapy. 285 
“I’ve got a friend who’s, well she’s retired now but she is a Psychotherapist and I’ve 286 
often thought, perhaps I should talk to X, because she knows my mum as well so 287 
well, she worked privately but she did do work for the NHS because she did work 288 
across there for the surgery at that time, but of course cutbacks, they cut all that sort 289 
of stuff out and they dish out the pills these days, more of them I think sadly.” P12 290 
          Some participants reported problems accessing talking treatments when 291 
signposted by their GP.  292 
“I think once you start offloading to one person and then you have to come home 293 
and make a phone call to go and see other counsellors, it puts people off because 294 
there are waiting times.  They’re ridiculously long.” P13 295 
For those who had been able to access psychological support, it was 296 
perceived as beneficial. 297 
"…this cognitive behaviour. And I found it really useful, because it's challenging your 298 
own thoughts, and I thought, yes, I am my own worst enemy." P7 299 
Overall, participants expressed a preference for non-pharmacological 300 
treatments, particularly psychological therapies. Some reported problems accessing 301 
treatment, recursively affecting future help-seeking, though those receiving 302 
psychological support perceived it to be helpful. 303 
 304 
Discussion 305 
 306 
Summary of findings 307 
Most participants recognised the negative impact of RA on their mood, with 308 
some also perceiving low mood or anxiety to precipitate RA flares, though several 309 
only acknowledged a link between RA and their mood when this was highlighted by 310 
a health care professional. 311 
Some participants lacked candidacy for care, normalising their mood 312 
problems as an expected response to suffering from RA. Others were prevented 313 
from seeking help due to fear of stigmatisation. Perceived prioritisation of physical 314 
above mental health concerns by GPs recursively affected help-seeking. A lack of 315 
time and poor continuity of care were reported as further barriers to disclosure. 316 
However, several participants reported establishing positive relationships with 317 
their GP and felt continuity of care with encouragement to attend follow-up would be 318 
integral to the disclosure of mental health concerns. 319 
Participants cited a preference for psychological therapies, though several 320 
reported problems accessing care. Whereas some participants were open to 321 
pharmacological treatments, others perceived medication to be offered as a ‘quick 322 
fix’ by their GP and feared potential drug interactions. 323 
 324 
Comparison with existing literature 325 
In common with other LTCs (25), this research suggests that patients with RA 326 
may recognise an interaction between their chronic physical illness and anxiety or 327 
depression. However, those who do not perceive a relationship between their mood 328 
problems and LTC may not understand the intention behind asking about mood 329 
during LTC reviews (26). 330 
 Patients with RA, in addition to other LTCs (27), can lack candidacy for care, 331 
failing to seek help for their anxiety and depression due to perceiving this to be a 332 
normal response to suffering from a chronic physical illness. 333 
Patients with LTCs may not seek help for mental health problems due to 334 
associated stigma (28). This finding was echoed in a study of Hispanic patients with 335 
RA (29), who perceived psychological problems as a sign of weakness. Further 336 
barriers to help seeking for anxiety and depression in patients with RA were 337 
identified within this study. These included a perception of GPs being dismissive of 338 
mental health concerns and appointments being anxiety-provoking, recursively 339 
affecting help-seeking. Further barriers to help-seeking included a lack of time and 340 
poor continuity of care. 341 
However, patients reported being more receptive to the discussion of mood 342 
concerns when they had established rapport with their GP. 343 
In common with existing literature (29, 30), patients with RA expressed a 344 
preference for talking treatments, wishing to avoid medication due to potential side-345 
effects or interactions with existing RA treatments. Patients with RA reported 346 
struggling to access psychological therapies due to long waiting times and perceived 347 
cuts in funding, suggesting a need for improvement in access to psychological 348 
support, as recognised in a survey of rheumatology nurses in 2012 (24).  349 
 350 
Strengths and Limitations 351 
 Use of qualitative methods with an exploratory approach ensured new 352 
phenomena were identified. A second stage of more detailed framework analysis 353 
enabled deeper insights into the barriers and facilitators to patients accessing care 354 
for psychological problems. 355 
 The topic guide was piloted with patients and practitioners to ensure face 356 
validity. This was also refined over the course of the study to ensure exploration of 357 
emerging themes. 358 
 A potential limitation was that only patients with a high PHQ-2 or GAD-2 359 
score were interviewed. It is likely that different views would have been articulated by 360 
patients who did not have anxiety or depression.   361 
Participants were predominantly retired White British females (reflecting the 362 
local demographics), hence a greater range of perspectives may have been obtained 363 
from a more diverse sample. Participants were identified and recruited through a 364 
secondary care clinic, meaning they were all from the same area of England. 365 
However, a range of different socioeconomic statuses were included (table 2). 366 
 367 
Implications for research and practice 368 
Although some patients with RA and co-morbid anxiety and/ or depression 369 
recognise the interaction between their arthritis and mood problems, others only 370 
make this link when it is highlighted by a clinician. Therefore, it is important that 371 
mood is explored as part of an annual review for RA patients, whether this is 372 
conducted in primary or specialist care, as improved recognition and management of 373 
anxiety and depression could lead to reduced overall morbidity and mortality. 374 
GPs need to give equal priority to mental and physical health problems to 375 
facilitate disclosure of distress. Provision of time during individual appointments and 376 
encouragement to attend follow-up with the same GP to support continuity of care 377 
could be integral to the disclosure of mood concerns.  378 
It is a policy imperative for improving access to psychological therapies (IAPT) 379 
to deliver care for people with depression and LTCs, hence, for patients who are 380 
anxious about self-referral, GPs should make referrals to IAPT. Given the negative 381 
impact of mood on outcomes in RA, such an intervention should be a priority. 382 
Given the primary care expertise in managing multimorbidity, developing 383 
practice nurse-led models of care may improve outcomes for patients with RA, 384 
providing patient and cost benefits by preventing duplication of care whilst enabling 385 
earlier intervention and management of multi-morbidities.  386 
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Table 1. The Case-Finding Questions for Anxiety and Depression 490 
(19, 20) 491 
 492 
Case-finding 
questions 
PHQ-2 GAD-2 
During the past month 
have you been 
bothered by… 
Feeling down, 
depressed or 
hopeless 
Feeling nervous, 
anxious or on edge 
Having little interest or 
pleasure in doing 
things 
Not being able to stop 
or control worrying 
 493 
Table 2. Characteristics of participants (n= 14) 494 
 495 
Gender Male = 2 
Female = 12 
Ethnicity White British = 14 
Age 
 
40-50 years = 1 
50-60 years = 4 
60-70 years = 7 
>70 years = 2 
Employment status Employed = 3 
Retired = 4 
Retired through ill health = 6  
Unemployed = 1 
Index of Multiple Deprivation (IMD) 
Measure of relative deprivation for 
neighbourhoods in England, expressed 
in deciles from 1 (most deprived) to 10 
(least deprived) 
Mean= 5.4 
Standard Deviation= 2.8 
Range= 1-9 
PHQ-2 Score Mean= 4.6 
Standard Deviation= 1.1 
GAD-2 Score Mean= 4.9 
Standard Deviation 1.1 
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